As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma. ...

Several rare immune disorders are caused by mutations in the patient's DNA. A Surrey team and collaborators found that targeting the mutated pathways with new drugs offers new hope for people ...

Researchers have discovered new connections between the gut and brain that hold promise for more targeted treatments for ...

We're recruiting the top figures in cancer research to work in a vibrant and confident culture that consistently produces world-changing research.

To join the ICR you’ll be a talented scientist looking for the next step after your initial postdoctoral studies. You’ll be ready to start leading a team independently under the mentorship of a ...